4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-006516
Director sold 10,964 shares at $9.81 ($107,575)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A Director | 2025-02-18 | Sale 10b5-1 | −10,964 | $9.81 | $107,575 | 708,295 | D |
| Open-market sales · 10,964 sh · avg $9.81 · $107,575 | |||||||
Loading xslF345X05/wk-form4_1740010306.xml…